Search
Showing results for "1"
A bivalent, recombinant, factor H-binding protein (rLP2086) vaccine was developed to protect against invasive Neisseria meningitidis serogroup B (MnB) in...
Improved nutrition is the major proven benefit of newborn screening programmes for cystic fibrosis (CF) and is associated with better clinical outcomes.
Our Centre is involved with a wide range of research projects, many involving collaborating with partners to run trials of new technologies and treatments.
We are excited to launch this first-of-its-kind Australian study, monitoring glucose levels in Australian children and adolescents who have tested positive to having one or more type 1 diabetes related antibodies but do not yet need treatment with insulin.
In early 2024, Dr Aveni Haynes and her team were awarded Telethon Trust funding for their project Supporting Families.
We hypothesised that adolescents with type 1 diabetes with a urinary albumin/creatinine ratio (ACR) in the upper tertile of the normal range (high ACR) are at greater risk of three-step diabetic retinopathy progression (3DR) independent of glycaemic control.
Read about the Research Focus Area Leads at the Children's Diabetes Centre.
Perth Children’s Hospital’s Diabetes Service has released the dates for its self-efficacy groups for 2020.
After more than 25 years in the diabetes space, clinical nurse and credentialled diabetes educator Maxine Schlaeppi has retired.v
Heidi Bucktin likes to think of her family’s life as pre and post continuous glucose monitoring – that’s how markedly different the two periods are in their journey of living with a child with type 1 diabetes.